Suchergebnisse - "Birkholz-Walerzak, Dorota"

PubPharm (12)

1

Personalized health risk assessment based on single-cell RNA sequencing analysis of a male with 45, X/48, XYYY karyotype

enthalten in: Scientific reports | 2022

von Koczkowska, M. | Jąkalski, M. | Birkholz-Walerzak, D. | +19

2

Bilateral Ovarian Germ Cell Tumor in a 46,XX Female with Nijmegen Breakage Syndrome and Hypergonadotropic Hypogonadism

enthalten in: Journal of clinical research in pediatric endocrinology | 2022

von Krawczyk, M. | Styczewska, M. | Birkholz-Walerzak, D. | +6

3

Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader-Willi Syndrome : A Polish Multicentre Study

enthalten in: Journal of clinical medicine | 2021

von Lecka-Ambroziak, A. | Wysocka-Mincewicz, M. | Doleżal-Ołtarzewska, K. | +14

4

Correlation of Genotype and Perinatal Period, Time of Diagnosis and Anthropometric Data before Commencement of Recombinant Human Growth Hormone Treatment in Polish Patients with Prader-Willi Syndrome

enthalten in: Diagnostics (Basel, Switzerland) | 2021

von Lecka-Ambroziak, A. | Wysocka-Mincewicz, M. | Doleżal-Ołtarzewska, K. | +13

5

Treatment of severe primary IGF-1 deficiency using rhIGF-1 preparation - first three years of Polish experience

enthalten in: Endokrynologia Polska | 2019

von Petriczko, E. | Jackowski, T. | Horodnicka-Józwa, A. | +22

6

Papillary thyroid carcinoma in a patient with Turner syndrome treated with human growth hormone

enthalten in: Pediatric endocrinology, diabetes, and metabolism | 2018

von Bautembach-Minkowska, J. | Birkholz-Walerzak, D. | Kędzia, A. | +1

7

Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

enthalten in: Advances in therapy | 2016

von Schwarz, H. | Walczak, M. | Birkholz-Walerzak, D. | +4

8

Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

enthalten in: Advances in therapy | 2016

von Schwarz, H. | Walczak, M. | Birkholz-Walerzak, D. | +4

9

Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

enthalten in: Advances in therapy | 2016

von Schwarz, H. | Walczak, M. | Birkholz-Walerzak, D. | +4

10

Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

enthalten in: Advances in therapy | 2016

von Schwarz, H. | Walczak, M. | Birkholz-Walerzak, D. | +4